Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Treatment Of Patients With Social Anxiety Disorder [Phase 2]
GlaxoSmithKline's Phase 2 trial for Social Anxiety Disorder has completed, according to the clinical trial update.
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Group Therapy Supported Internet-based CBT for Adolescents With Social Anxiety Disorder - A Feasibility Trial [NA]
A completed feasibility trial evaluated group therapy-supported internet-based cognitive behavioral therapy for adolescents with social anxi…
-
FDA approval · 2017-06-15FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by ROERIG, indicating an approved modification to th…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder [Phase 3]
A Phase 3 trial evaluated adding cognitive behavioral therapy to drug treatment for social anxiety disorder; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Primary Care Intervention Strategy for Anxiety Disorders [Phase 4]
Phase 4 trial update reporting results of a primary care intervention strategy for anxiety disorders, including PTSD and generalized anxiety…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Treatment of Social Anxiety in Youth [NA]
This document notes the completion of a clinical trial evaluating treatment for social anxiety disorder in youth.
-
FDA approval · 2017-04-28FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA has approved a supplemental application for paroxetine filed by Padagis US LLC. This notice indicates FDA approval of an amendment t…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults [Phase 4]
Phase 4 trial evaluating adjunctive quetiapine for adults with refractory social anxiety disorder has completed. The document provides an up…
-
FDA approval · 2017-03-24FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved a generic venlafaxine hydrochloride product from Westminster Pharmaceuticals, LLC under an Original Application. This approval …
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Virtual Reality Exposure Therapy Versus Exposure in Vivo for Social Phobia [NA]
This update reports the completion of a clinical trial comparing virtual reality exposure therapy to exposure in vivo for social anxiety dis…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
A completed clinical trial update assessing whether phases of the menstrual cycle influence blood levels of lithium and sertraline in indivi…
-
FDA approval · 2017-01-20FDA Approved: PAROXETINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for Paroxetine, a generic selective serotonin reuptake inhibitor. The approval expa…
-
FDA label_change · 2017-01-04FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental labeling change for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC. The supplemental …
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC, likely related to labeling cha…
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, Inc., indicating approval of a change to the exi…
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental ANDA for venlafaxine by Heritage Pharmaceuticals (Avet) to bring a generic version to the market.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for venlafaxine hydrochloride (generic venlafaxine) from Aurobindo Pharma Limited.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Alembic Pharmaceuticals Inc. under an approved ANDA.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application from BluePoint Laboratories for Venlafaxine (venlafaxine hydrochloride), a generic antidepressan…
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride (venlafaxine HCl) from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Imagery-based CBT for Social Anxiety Disorder: Piloting a Treatment Augmentation Protocol [NA]
Completed study evaluating imagery-based cognitive-behavioral therapy as an augmentation strategy for Social Anxiety Disorder.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Retraining Attention to Treat Alcohol Dependence and Social Anxiety [NA]
A completed clinical trial evaluating attention retraining to treat alcohol use disorder and social anxiety disorder. Results were posted in…
-
FDA approval · 2016-12-23FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride (generic) manufactured by Mylan Pharmaceuticals Inc.; this represen…
-
FDA approval · 2016-11-25FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for a venlafaxine hydrochloride generic product from BluePoint Laboratories under ANDA077653. Th…
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Self-help for Treating Social Anxiety Disorder: An Evaluation of a Mindfulness and Acceptance-based Approach [NA]
This completed clinical trial evaluated a mindfulness- and acceptance-based self-help program for social anxiety disorder. The study was spo…